Details for 2017814223
Up to date per 01.04.2026
Actions
Details for 2017814223
Granted/Registered
European Patent
24.04.2019 A
28.10.2020 B1
16.06.2016
US
201662351234 P
A61K 48/00 20060101AFI20190220BHEP
Owner
Adverum Biotechnologies, Inc.1035 O'Brien Drive Suite A Menlo Park, California 94025US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
BLUMENKRANZ, Mark1035 O'Brien Drive Suite A Menlo Park, CA 94025US
GASMI, Mehdi1035 O'Brien Drive Suite A Menlo Park, CA 94025US
Information about Fees